{
  "paper_metadata": {
    "pmid": "38396973",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted information on the TTR gene variant Val30Met, including penetrance data and patient details."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.149G>A",
      "protein_notation": "p.Val50Met",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 3000,
        "demographics": "not specified",
        "phenotype": "ATTR-FAP with autonomic dysfunction"
      },
      "penetrance_data": {
        "total_carriers_observed": 3000,
        "affected_count": 1760,
        "unaffected_count": 1240,
        "uncertain_count": null,
        "penetrance_percentage": 58.7,
        "age_dependent_penetrance": []
      },
      "individual_records": [],
      "functional_data": {
        "summary": "Autonomic dysfunction is prominent and disabling in patients with ATTR-FAP.",
        "assays": []
      },
      "segregation_data": "Yes, segregates with disease in families.",
      "population_frequency": null,
      "evidence_level": "strong",
      "source_location": "Results, paragraph 4",
      "additional_notes": "Val30Met is the most common mutation in the TTR protein in Western countries and Japan.",
      "key_quotes": [
        "Autonomic dysfunction has been reported as an initial symptom in more than 40% of Japanese ATTR-FAP Val30Met patients.",
        "In a study involving more than 3000 subjects enrolled in a multinational, longitudinal, observational Transthyretin Amyloidosis Outcomes Survey (THAOS), 58.7% had symptomatic orthostatic hypotension."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "Extracted data focused solely on the TTR gene variant Val30Met."
  }
}